...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: How is Zenith affected by the RVX top line miss

,,,my xmas wish list is,,,,,,RVX finds important data confirming inflammation reduction from within the BoM trial,,,,,,that Zenith puuuks out important and ecouraging data from their trials,,,,,that Management sees the need to list Zenith on an exchange,,,,preferable the Nasdaq,,,,,,,and that good news will trigger market cap valuations to the upside for both companies,,,,,will it happen,,,,,,,,no idea,,,,but one thing is guarranteed,, praying will not help one iota,,,,,,,,,,,,,,,, 

Share
New Message
Please login to post a reply